Patients with DN and increased urine IgM excretion, either in the micro or the macroalbuminuric stage, had at least a threefold higher risk of CV mortality and renal failure than those with low urinary IgM excretion, (Table 4, Figures 1 and 2). This evidence concerns the gene CD40LG and kidney failure.